Notice of EGM: vote on a proposed issue and free allocation of warrants to shareholders
2026-04-20
The Company announces that an Extraordinary General Meeting has been convened to vote on a specific delegation of authority to the Board of Directors for the implementation of a proposed issuance of share subscription warrants (BSA) to be allocated free of charge to shareholders.
This Extraordinary General Meeting will be held on May 26, 2026 at 5:00 p.m., in accordance with the notice published in the official announcement registry “BALO” on April 17, 2026. The conditions for participation and all preparatory documents will be made available to shareholders on the Company’s website, under the “General Meeting” section.
AN OPERATION THAT FULLY RESPECTS SHAREHOLDERS’ RIGHTS
The proposed transaction, which would be implemented by the Board of Directors if approved by the Extraordinary General Meeting, is based on the free allocation of BSA to all existing shareholders, in proportion to their shareholding.
This structure guarantees compliance with the principle of equal treatment among shareholders: no reserved tranche and no waiver of shareholders’ preferential subscription rights is contemplated in this context.
Following the free allocation, each shareholder would therefore have the option to retain, sell or exercise their BSA under the terms and conditions to be determined by the Board of Directors.
INVOLVING SHAREHOLDERS IN THE COMPANY’S NEXT PHASE OF EXPANSION
The resolution submitted to shareholders’ vote is intended to provide the Board of Directors with a financial instrument enabling shareholders to support the Company’s next phase of expansion.
Although the Board of Directors already holds certain financial delegations, it has decided to submit this project directly to shareholders’ vote, in the interest of transparency and sound governance.
Subject to the approval of the Extraordinary General Meeting, the Board of Directors would decide on the implementation of this transaction and determine its terms and conditions (parity ratio, timetable, exercise price and if applicable, listing for trading), in the Company’s best interests and depending on market conditions.